Emergent BioSolutions Inc. ( EBS) - Key Metrics
EBS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.78 | -$1.02 | $1.45 | $1.38 |
| 2025Q3 | $4.34 | $0.96 | -$0.04 | -$0.11 |
| 2025Q2 | $2.60 | -$0.22 | $1.96 | $1.91 |
| 2025Q1 | $4.08 | $1.25 | -$0.21 | -$0.27 |
EBS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.03 |
| 2025Q3 | ? | 2.29 |
| 2025Q2 | ? | -7.20 |
| 2025Q1 | ? | 0.97 |
EBS
Price: $8.07
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 633400
Ebitda: 58.1 millionMarket Capitalization: 423.3 million